Dr. Victor M. Pinto-Plata, MD

Dr. Pinto-Plata practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Pinto-Plata's NPI, 1134114085, was assigned on September 16, 2005. Dr. Pinto-Plata holds Massachusetts license 80624.

Dr. Pinto-Plata's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Pinto-Plata's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Pinto-Plata is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Pinto-Plata to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pinto-Plata practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Pinto-Plata's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Pinto-Plata is licensed in Massachusetts.

CMS data shows 1,052 Medicare services from Dr. Pinto-Plata across 19 procedure codes in 2024, for 527 Medicare patients. Medicare paid $62,881 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 527 Medicare patients who saw Dr. Pinto-Plata in 2024. The largest group is 75 to 84, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pinto-Plata's median patient age at 74, with 56% women.

In 2024, Dr. Pinto-Plata wrote 904 Medicare Part D claims for 167 patients. 33% of them were for generic drugs. CMS names the drug for 802 of them, across 23 drugs with 11 or more claims each, at $576,700 in total drug cost. In 2023, CMS named 586 claims across 20 drugs.

Dr. Pinto-Plata accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pinto-Plata as offering telehealth.

Dmand AI links 63 papers to Dr. Pinto-Plata, published from 2005 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Pulmonary Disease, Chronic Obstructive, Forced Expiratory Volume and Lung. Dr. Pinto-Plata has published most often in Am J Respir Crit Care Med. Dr. Pinto-Plata's most frequent co-authors are Bartolome R. Celli, MD, Miguel Jose Divo, MD and Francesca Polverino, MD, PhD.

Dmand AI links Dr. Pinto-Plata to 2 clinical trials. Conditions studied include Lung Neoplasms, Weight Loss and Body Weight Changes. Open Payments lists research payments to Dr. Pinto-Plata that name 1 trial.

CMS Open Payments shows 106 general payments to Dr. Pinto-Plata from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. GlaxoSmithKline, LLC. paid the most, $15,369. It also lists 2 research payments totaling $750 in 2025, naming 1 clinical trial.